A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury (opens ClinicalTrials.gov)
- Sponsor
- NervGen Pharma
- Enrolment
- 150
- Started
- 2026-09-28
- Last update
- 2026-11-04
Conditions: Chronic Spinal Cord Injury
Interventions: NVG-291, Placebo